While addressing people at an award programme in Pune, Maharashtra, on Wednesday, where Cyrus Poonawala was also present, Sharad Pawar pointed out how the Serum Institute's vaccine has proved effective for many diseases, including COVID, and how big their contribution is.
As Cervical cancer is second leading cause of deaths among women in India, the central government had announced plans to encourage vaccinations against the human papillomavirus (HPV) through its immunisation programme, is exploring options to cap prices so that the vaccines to treat cervical
The National Technical Advisory Group for Immunisation (NTAGI) has recommended introduction of The quadrivalent Human Papilloma Virus (qHPV) vaccine in the Universal Immunization Programme (UIP) with a one-time catch-up for 9-14 year-old adolescent girls followed with routine introduction
Now, a new study in infant mice shows that keeping virus particles from attaching to SAs limits more than just the entry of influenza A viral infections, but also hinders their exit (shedding) and transmission from mouse to mouse. Such infections are the main cause of the seasonal flu that k
The people who get tuberculosis are largely poor people who can't pay for treatments. That's an example of an investment that is not focused on India, but if it works, it will have very high benefits for India, which has a high TB burden," the CEO said, referring to India's ambitious tube
Mumbai (Maharashtra) [India], January 25: As the nation gears up to celebrate Republic Day, Star Gold takes immense pride in presenting the world television premiere of 'The Vaccine War'- a cinematic journey that encapsulates India's triumphant battle against the COVID-19 pandemic through th
The world's largest vaccine manufacturer, the Serum Institute of India Private Ltd (SII), is joining a growing Coalition for Epidemic Preparedness Innovations (CEPI) network of vaccine producers in the Global South to support more rapid, agile, and equitable responses to future public health
Indian Immunologicals Ltd. (IIL), a wholly-owned subsidiary of the National Dairy Development Board (NDDB) and a biopharmaceutical company in India, launched India's first indigenously developed Hepatitis A vaccine, 'Havisure'.
n a significant step towards ensuring animal healthcare and boosting self-sufficiency in livestock vaccines, the Odisha government has signed a Memorandum of Understanding (MoU) with the National Dairy Development Board (NDDB) for establishing a Good Manufacturing Practice (GMP) facility at
Former AIIMS director and senior pulmonologist, Dr Randeep Guleria said that the new subvariant of COVID is not causing severe infections and hospitalisation.
Amid a surge in COVID cases in India and the detection of a subvariant JN.1, India SARS-CoV-2 Genomics Consortium (INSACOG) chief Dr NK Arora said that no additional dose of vaccine is required against the subvariant at the present stage.
Researchers discovered a previously unknown class of antibodies--immune system proteins that guard against disease--that appear to be capable of neutralising different strains of flu virus.